Clin2
NCT06687694Possibly a fitRecruiting

How antipsychotics affect the immune system in psychosis

Psychosis

Part of Brain & nervous system, Mental health clinical trials.

This study looks at how antipsychotic medicines affect the immune system in people with psychosis. By taking blood samples before and after starting or changing medication, researchers hope to understand why some people respond better to treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
500 people
Ages
18 years to 65 years
Study type
Observational

Who can take part

  • You are between 18 and 65 years old.
  • You currently have symptoms of psychosis that need treatment from a mental health team.
  • You are about to start a new antipsychotic medicine, switch to a different one, or restart one you stopped for at least two weeks.
  • You are not taking medications that strongly affect your immune system (like steroids or certain antibody treatments) in the last 4 weeks.
  • You are able to have blood tests (and possibly a spinal tap, depending on the study part).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06729671Recruiting
Probiotics for antipsychotic-related metabolic issues

This trial tests if a probiotic supplement can help reduce metabolic side effects (like weight gain or high blood sugar) caused by antipsychotic medications. It is for people with psychosis who are on stable treatment.

Cork
NCT06634641Recruiting· Phase 4
Clozapine and immune function in Parkinson's disease

This trial tests whether clozapine, a medication for psychosis in Parkinson's disease, affects the immune system. It involves regular blood monitoring to help keep patients safe.

Salouël
NCT05316883Recruiting· Phase 4
Testing blood markers in people on clozapine for schizophrenia

This study looks at “biomarkers,” or blood measures, in people with schizophrenia who respond to clozapine. It may help researchers understand who benefits from clozapine and why, by linking test results to symptom changes.

Glostrup Municipality, Denmark
NCT07386483Not yet recruiting
Strength training timing to prevent antipsychotic weight gain

This trial tests if doing resistance training at a specific time of day can help prevent the metabolic side effects (like weight gain and blood sugar changes) caused by antipsychotic medications in people recently diagnosed with psychosis.

Dublin
NCT07791212Not yet recruiting
Immune system study for brain and psychiatric conditions

This study looks at how the immune system might be involved in brain and psychiatric conditions. They will compare people with such conditions to healthy controls, using blood tests and possibly a spinal tap to look for immune markers.

London
NCT06673966Recruiting
Schizophrenia brain and immune health study

This study looks at how immune system health relates to brain changes in people with schizophrenia. It uses brain imaging and electrical activity tests to understand these connections.

Changsha, Hunan

Hear when a new Psychosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.